Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases—Is There Any Benefit of PAH-Specific Therapy?
Abstract
Share and Cite
Szturmowicz, M.; Kacprzak, A.; Kuś, J. Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases—Is There Any Benefit of PAH-Specific Therapy? Adv. Respir. Med. 2017, 85, 216-223. https://doi.org/10.5603/ARM.2017.0036
Szturmowicz M, Kacprzak A, Kuś J. Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases—Is There Any Benefit of PAH-Specific Therapy? Advances in Respiratory Medicine. 2017; 85(4):216-223. https://doi.org/10.5603/ARM.2017.0036
Chicago/Turabian StyleSzturmowicz, Monika, Aneta Kacprzak, and Jan Kuś. 2017. "Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases—Is There Any Benefit of PAH-Specific Therapy?" Advances in Respiratory Medicine 85, no. 4: 216-223. https://doi.org/10.5603/ARM.2017.0036